How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients With and Without Previous Cardiovascular Disease?
Journal article
Canoy D. et al, (2022), Current Cardiology Reports
The Blood Pressure Lowering Treatment Trialists' Collaboration: methodological clarifications of recent reports.
Journal article
Nazarzadeh M. et al, (2022), J Hypertens
Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials
Journal article
Canoy D. et al, (2022), Heart
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.
Journal article
Nazarzadeh M. et al, (2021), Lancet, 398, 1803 - 1810
Blood pressure treatment: how low should you go? - Authors' reply.
Journal article
Rahimi K. et al, (2021), Lancet, 398, 1684 - 1685
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis.
Journal article
Blood Pressure Lowering Treatment Trialists' Collaboration None., (2021), Lancet, 398, 1053 - 1064
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual level meta-analysis of 145,000 randomized participants
Journal article
CANOY D. et al, (2021), The Lancet
Age and blood pressure stratified effects of blood pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual-level meta-analysis of 358,707 randomised participants
Journal article
MCMANUS R. et al, (2021), The Lancet
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis
Journal article
Pinho-Gomes A-C. et al, (2021), PLOS Medicine, 18, e1003599 - e1003599
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis
Conference paper
Pinho-Gomes AC. et al, (2021), PLoS Medicine, 18
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
Journal article
Rahimi K. et al, (2021), The Lancet, 397, 1625 - 1636
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
Journal article
Copland E. et al, (2021), The Lancet Oncology, 22, 558 - 570
BLOOD PRESSURE LOWERING TREATMENT FOR PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: AN INDIVIDUAL-PARTICIPANT DATA META-ANALYSIS
Conference paper
Pinho-Gomes ACP. et al, (2021), JOURNAL OF HYPERTENSION, 39, E80 - E80
BLOOD PRESSURE-LOWERING, ANTIHYPERTENSIVE TREATMENT AND INCIDENT DIABETES
Conference paper
Nazarzadeh M. et al, (2021), JOURNAL OF HYPERTENSION, 39, E8 - E9
STRATIFIED EFFECTS OF BLOOD PRESSURE-LOWERING TREATMENT ON LONG-TERM BLOOD PRESSURE: A META-ANALYSIS OF INDIVIDUAL-LEVEL DATA OF 334,219 PARTICIPANTS FROM 50 RANDOMIZED TRIALS
Conference paper
Canoy D. et al, (2021), JOURNAL OF HYPERTENSION, 39, E53 - E53
YY EFFECTS OF BLOOD PRESSURE-LOWERING ON CANCER RISK: AN INDIVIDUAL PARTICIPANT DATA META-ANALYSIS OF 300,000 PARTICIPANTS
Conference paper
Copland E. et al, (2021), JOURNAL OF HYPERTENSION, 39, E7 - E7
Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation: A Mendelian randomization study
Journal article
NAZARZADEH LARZJAN M. et al, (2021), Genome Medicine
Effect of blood pressure lowering treatment on the risk of atrial fibrillation: an individual-participant data meta-analysis
Conference paper
Pinho-Gomes AC. et al, (2020), EUROPEAN HEART JOURNAL, 41, 2771 - 2771
Stratified effects of blood pressure-lowering treatment on long-term blood pressure: an individual patient-level meta-analysis involving 50 randomised trials and 334,219 participants
Conference paper
Canoy D. et al, (2020), EUROPEAN HEART JOURNAL, 41, 2762 - 2762